Cytokinetics (NASDAQ:CYTK – Get Free Report) and Fulcrum Therapeutics (NASDAQ:FULC – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation. Analyst Ratings This is a breakdown of current recommendations […]
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2024 EPS estimates for shares of Fulcrum Therapeutics in a note issued to investors on Monday, May 20th. Cantor Fitzgerald analyst K. Kluska forecasts that the company will earn ($0.78) per share for the year. Cantor Fitzgerald currently has a […]
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) – Leerink Partnrs upped their Q2 2024 earnings per share (EPS) estimates for shares of Fulcrum Therapeutics in a report released on Monday, May 13th. Leerink Partnrs analyst J. Schwartz now anticipates that the company will post earnings per share of $0.74 for the quarter, up from their […]
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) – Research analysts at HC Wainwright decreased their Q2 2024 earnings per share (EPS) estimates for Fulcrum Therapeutics in a report issued on Tuesday, May 14th. HC Wainwright analyst A. Fein now forecasts that the company will post earnings of ($0.43) per share for the quarter, down from […]
Rx Rundown: Sanofi, Bayer, Sands Capital and more mmm-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mmm-online.com Daily Mail and Mail on Sunday newspapers.